Sensus Healthcare (SRTS) Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SRTS shares.
View SRTS analyst ratings or view top-rated stocks.

3 brokers have issued twelve-month target prices for Sensus Healthcare's stock. Their SRTS share price forecasts range from $7.00 to $20.00. On average, they predict the company's stock price to reach $12.33 in the next twelve months. This suggests a possible upside of 323.8% from the stock's current price.
View analysts price targets for SRTS or view top-rated stocks among Wall Street analysts.

Sensus Healthcare's stock was trading at $7.42 at the start of the year. Since then, SRTS shares have decreased by 60.8% and is now trading at $2.91.
View the best growth stocks for 2023 here.

Sensus Healthcare saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 326,900 shares, a drop of 26.7% from the April 30th total of 446,100 shares. Based on an average daily trading volume, of 241,800 shares, the days-to-cover ratio is currently 1.4 days. Approximately 2.5% of the company's stock are sold short.
View Sensus Healthcare's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our SRTS earnings forecast.

Sensus Healthcare, Inc. (NASDAQ:SRTS) posted its quarterly earnings data on Wednesday, May, 3rd. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by $0.23. The business had revenue of $3.41 million for the quarter, compared to analysts' expectations of $9.24 million. Sensus Healthcare had a net margin of 16.73% and a trailing twelve-month return on equity of 13.49%.

First Trust Dow Jones Select Microcap Index Fund holds 34,469 shares of SRTS stock, representing 0.12% of its portfolio.

Based on aggregate information from My MarketBeat watchlists, some companies that other Sensus Healthcare investors own include Ring Energy (REI), Sorrento Therapeutics (SRNE), Corbus Pharmaceuticals (CRBP), Nabriva Therapeutics (NBRV), Sangamo Therapeutics (SGMO), Viking Therapeutics (VKTX), Vaxart (VXRT), Amarin (AMRN), Palatin Technologies (PTN) and QUALCOMM (QCOM).

(SRTS) raised $20 million in an initial public offering on Wednesday, March 30th 2016. The company issued 1,800,000 shares at $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company acted as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager.

Sensus Healthcare trades on the NASDAQ under the ticker symbol "SRTS."

Sensus Healthcare's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Acadian Asset Management LLC (3.89%), Punch & Associates Investment Management Inc. (2.58%), Renaissance Technologies LLC (1.63%), Empirical Financial Services LLC d.b.a. Empirical Wealth Management (1.14%), Geode Capital Management LLC (0.78%) and Dimensional Fund Advisors LP (0.77%). Insiders that own company stock include Javier Rampolla, John Heinrich, Joseph C Sardano, Michael Sardano, Nicolas Soro, Samuel O'rear, Stephen Brad Cohen and William H Mccall.
View institutional ownership trends.

Shares of SRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SRTS stock can currently be purchased for approximately $2.91.

Sensus Healthcare (NASDAQ:SRTS) has a market capitalization of $47.72 million and generates $44.53 million in revenue each year. The company earns $24.24 million in net income (profit) each year or $0.37 on an earnings per share basis.

Sensus Healthcare's mailing address is 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487. The official website for the company is www.sensushealthcare.com. The company can be reached via phone at (561) 922-5808, via email at kgolodetz@lhai.com, or via fax at 561-948-2071.